About Amgen (AMGN)
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis... Read more
- USD297.00
- USD298.99
- USD295.51
- USD346.85
- 2.90%
- 34.1B
- 1.52M
- 2.88M
- 149.0B
- 253.30
- -4.50%
- 14.30%
Stock News
3 hours ago
The one thing that’s driving home sellers bananas — and making buyers happy
MarketWatch
4 hours ago
Why Tripadvisor Stock Is on the Map Today
Yahoo
4 hours ago
Cramer sees jobs data as a win for Fed's Powell over Trump — plus, possible stocks to trim
CNBC
4 hours ago
Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
